Isabel T. Rubio

rubio 210x210
President of EUSOMA and Co-Chair of Prevention Network, European Cancer Organisation


Isabel T. Rubio is the Head of Breast Surgical Oncology at Clinica Universidad de Navarra in Madrid, Spain and Professor of Surgery at the Universidad de Navarra, Spain.  She completed her Medical degree at the Faculty of Medicine in Salamanca, Spain, and become a Board certified General Surgeon. She had additional training for two years as a Breast Surgical Oncology Fellow at The University of Arkansas for Medical Sciences and the Arkansas Cancer Center at Little Rock, USA and for one year at the MD Anderson Cancer Center in Houston, Texas, USA. She completed her PhD in 2000. She is the director of the Breast Surgery Fellowship program at her Institution.

Dr. Rubio is active in many societies, founding member and past President of the Spanish Association of Breast Surgeons (AECIMA), EUSOMA President-Elect (European Society of Breast Cancer Specialists), Chief, Public Affairs of the European Society of Surgical Oncology (ESSO), member of the American Society of Breast Surgeons and member of the Outreach Committee of the Society of Surgical Oncology (SSO).  She is the breast section editor of the Journal of Surgical Oncology, reviewer for The Breast, the European Journal of Surgical Oncology and Annals of Surgical Oncology. She obtained the European Board of Surgery Qualification in Breast Surgery and since 2015 is officer at the UEMS Breast Surgery Division and participates as an examiner in the EBSQ Examinations in Breast Surgery.

Dr. Rubio is involved as part of the Steering and Executive Committees in several international, multicenter randomized trials. She has received grants to develop her research by the Susan G. Komen Foundation, Spanish Ministry of Health and other institutions. Dr. Rubio has published over 100 national and international peer review manuscripts and book chapters. She has presented her work in many of the main international meetings in breast cancer.

Her interest is in sentinel lymph node biopsy, neoadjuvant treatments, surgical management of BRCA mutation carriers and the role of prognostic markers (genomic profiles, liquid biopsy). Also her interest is focused on the standardization of Breast cancer surgical training and Breast units.


Updated: May 2020